Where does InCube Labs, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), InCube Labs, LLC ranks #3,229 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does InCube Labs, LLC hold?

InCube Labs, LLC holds 116 US utility patents granted between 2015 and 2025, spanning 41 technology areas.

What is InCube Labs, LLC's Innovation Score?

InCube Labs, LLC has an Innovation Score of 57.2 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does InCube Labs, LLC focus on?

InCube Labs, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 49 patents, ranking #76 of 1,943 assignees active in that subclass. Grants appear in 41 CPC subclasses total.

Is InCube Labs, LLC's patent grant rate increasing or decreasing?

InCube Labs, LLC's recent grant velocity is -65% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for InCube Labs, LLC's patents?

InCube Labs, LLC's patents average 25.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the InCube Labs, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

InCube Labs, LLC

USPTO PatentsView assignee record - 116 granted patents across 41 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Incube ranks #3,229 of 49,997 tracked US assignees by granted-patent volume, with 116 patents across 41 technology areas.

#3,229
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.2/100): 25.6
avg claims per patent: -65%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3229 · US Corporation #3,229 · 116 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 116 grants
TOP-DECILE #3,229/49,997
PHOTO-FINISH Fujifilm Healthcare
CPC-WIDE A61N · 41 areas
INNOV-PAR 57.2/100
CLAIMS-DENSE 25.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -65% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fujifilm Healthcare Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Incube’s 57.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.5 pts (29%) Velocity 3.1 pts (5%) Breadth 22.6 pts (40%) Claim depth 15.0 pts (26%)

Qualcomm Incorporated · highest

85
Bayer Cropscience… · near

57
Elucid Bioimaging · near

57
InCube Labs · this assignee

57
Sakuu · near

57
Givaudan · near

57
3D Lighting… · lowest

7

What this shows Incube's Innovation Score is 57.2/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Incube?

Each dot is one of Incube’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Incube’s own 25.6 claims/patent is ABOVE the 12.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Incube vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Incube's grants concentrate

InCube Labs, LLC is a focused PatentsView assignee: 41 CPC subclasses with 42.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (24 grants) versus a trough of 2 in 2021. By volume, Incube sits between Fujifilm Healthcare Corporation and Leia Inc..

Incube's three-year grant acceleration

From 2019–2021 to 2022–2024, InCube Labs, LLC moved from 34 to 16 grants (0.47x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,762. See the growth leaderboard.

Fujifilm Healthca…

116
Hitachi Medical

116
Hach

116
Hasbro

116
KOA

116
Korea Hydro & Nuc…

116
Kyocera AVX Compo…

116
Leia

116
Incube Labs ◀

116

What this shows InCube holds 116 patents at rank #3,229, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near InCube

By rank, the assignees closest to #3,229 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in InCube's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for InCube, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), InCube ranks #76 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Bayer Cropscience Aktiengesellschaft 57 Elucid Bioimaging Inc. 57 Sakuu Corporation 57 Givaudan SA 57

Similar claim depth

Nearest assignees by average claims per patent (25.6 here).

InVue Security Products Inc. 25.6 avg Evolution Engineering Inc. 25.6 avg Sandisk IL Ltd. 25.6 avg Qualcomm Mems Technologies, Inc. 25.6 avg

Incube's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

InCube Labs, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	17	14.7%
2016	7	6.0%
2017	17	14.7%
2018	24	20.7%
2019	20	17.2%
2020	12	10.3%
2021	2	1.7%
2022	4	3.4%
2023	6	5.2%
2024	6	5.2%
2025partial year	1	0.9%

Which technologies does InCube Labs, LLC patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 49

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 46

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 41

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

A61B - DIAGNOSIS; SURGERY; Identification 27

B63C - Launching, Hauling-out, OR Dry-docking OF VESSELS; Life-saving IN WATER; Equipment FOR Dwelling OR Working Under WATER; Means FOR Salvaging OR Searching FOR Underwater Objects 10

C07K - Peptides 9

H04B - Transmission 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 5

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 4

G06F - Electric Digital Data Processing 4

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 4

Top 15 of 41 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

InCube Labs, LLC's patent record in context - here's where to go next.

InCube Labs, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 42.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #3,229 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare InCube Labs, LLC against Fujifilm Healthcare Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.